exendin-4 tirzepatide

exendin-4 tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Mechanism of action (MOA) of

Name: exendin-4 tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Mechanism of action (MOA) of
Brand: eric-jean.com
SKU: 65157947564
Price: 21.25 USD
Availability: InStock
Rating: 4.3573 (23 reviews)

SKU: 65157947564

4.4

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 28 - Oct 3

Description

This product is not intended to diagnose, treat, cure, or prevent any disease.)

Retatrutide is an 'investigational molecule and cannot legally be sold to the public' The drug is currently undergoing a clinical trial with manufacturer Eli Lilly, the company which produces Mounjaro, with Phase 3 clinical trials to test the medication's effectiveness for weight loss and type 2 diabetes currently ongoing